BL
IMUX icon

BFSG LLC’s Immunic IMUX Stock Holding History

BFSG LLC’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300
Closed -$3K – 693
2024
Q4 		$3K Hold
300
– – ﹤0.01% 588
2024
Q3 		$4.95K Hold
300
– – ﹤0.01% 543
2024
Q2 		$3.33K Hold
300
– – ﹤0.01% 544
2024
Q1 		$3.96K Hold
300
– – ﹤0.01% 559
2023
Q4 		$4.5K Buy
+300
New +$3.68K ﹤0.01% 510

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BFSG LLC's IMUX Position: Q1 2025 in Review

BFSG LLC sold out of Immunic (IMUX) in Q1 2025, closing a stake of 300 shares — an estimated $3K sold.

BFSG LLC first reported a position in IMUX in Q4 2023 and held it in 5 quarters. The position peaked at $4.95K in Q3 2024. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.

  • BFSG LLC reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
  • BFSG LLC sold 300 Immunic shares in Q1 2025, an estimated $3K.
  • BFSG LLC first reported a position in Immunic in Q4 2023 and held it in 5 quarters.
  • BFSG LLC's Immunic position peaked at $4.95K in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.

Based on BFSG LLC's 13F filing for Q1 2025, filed 18 Apr 2025.